chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SWOLLEN AND RED, WARM TO TOUCH, HE SAYS IT FEELS TIGHT. ORAL TEMP. 99.6. SYMPTOMS NOTICED AT 8:30 AM 07/15/05. PUSTULE NOTED AT INJECTION SITE WITH WHITE SPECK.
Case number PHEH2014US021746, is an initial spontaneous report received from a nurse on 27 Oct 2014 and with follow-up information received from a physician on 16 Dec 2014. This report refers to a 16 years old female patient. Past medical history and concomitant medication were not reported. She received only Men C, Y, W-135 liquid conjugate component of MENVEO (batch number: X14041), intramuscularly into right arm without being reconstituted with Men A lyophilized conjugate vaccine component on 27 Oct 2014 at 17:45. On an unknown date she was re administered with the vaccine correctly. No adverse event was reported following this administration error. Follow-up information received from a physician on 16 Dec 2014: Patient's demographics (height and weight), vaccination details (site and time) and revaccination details were updated. Batch number was changed to X14041 from X14030.
G40.909 EPILEPSY, UNSPECIFIED 12/20/2022 BRAIN MASS J96.00 ACUTE RESPIRATORY FAILURE 12/20/2022 BRAIN MASS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 BRAIN MASS G40.909 EPILEPSY, UNSPECIFIED 12/20/2022 GLIOBLASTOMA MULTIFORME, BRAIN, UNSPECIFIED SITE J96.00 ACUTE RESPIRATORY FAILURE 12/20/2022 GLIOBLASTOMA MULTIFORME, BRAIN, UNSPECIFIED SITE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 GLIOBLASTOMA MULTIFORME, BRAIN, UNSPECIFIED SITE
4/12 Patient was brought by family to ED for excessive fatigue, dry cough and poor PO intake.  He was positive for SARS CoV-2 and had some hyponatremia. Date of onset of symptoms: ~Approximately 5 days Date of covid positive test: 4/12/21 Symptoms: dry cough and fatigue Imaging: Chest x-ray?No significant abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated Of note it has been reported the patient is approximately 2 weeks out from second Covid vaccine injection.  His son reports that one day about 2 weeks ago he escaped out of his home into a crowded bar and apparently there were 7 others there who tested positive. .  Appreciate Dr's assistance - reswab sent for CT value.  CT values were 18.5/19 which are consistent with concern for active disease. He was given monoclonal antibody in-house on the day of discharge
Patient received hpv vaccine on 7/29/09 on right arm.  Reaction on 7/30/09 about 24 hours after vaccine was administered.  Area has swelling, is red and warm to touch. Redness is about 2 inches in diameter and 4 inch in length. Nurse documented vaccine given IM, client's mother states vaccine was given sub Q.  Reaction is in the back part of the right arm.
Information has been received from a physician concerning a female who was vaccinated with GARDASIL (LOT # was not provided). After receiving GARDASIL the patient experienced syncope. The outcome of the patient was unknown. The patient didn't seek medical attention. Follow-up information has been received from the physician concerning the 11 (also reported as 12) year old patient with a history of fainting in July 2008 (The patient was seen by a cardiologist) who has one sibling. The patient was examined and vaccinated intramuscularly with the first dose of GARDASIL in the physician's office on 24-JUL-2009 at about 2:00 pm. There was no concomitant medication. The patient was alert and intelligent, vital signs were normal. After vaccination, the patient was sitting in the waiting area and began to faint. The patient appeared pale and dusky. The patient was immediately offered oral fluids and saltine crackers. At the time of the report, the patient recovered. Additional information has been requested.
started getting sick; headache; muscle pain; joint pain; chills; throat is hurting bad; eyes hurt; urinating a lot; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure (High Blood Pressure) since an unknown date and Acid reflux (oesophageal) since an unknown date. Concurrent medical conditions included Drug allergy (Codeine allergy), Paracetamol (Tylenol allergy), Drug allergy (Morphine allergy) and Drug allergy (Statins Allergy). Concomitant products included OMEPRAZOLE (OMEPRAZOLE ACID REDUCER) and MELOXICAM for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), OROPHARYNGEAL PAIN (throat is hurting bad), EYE PAIN (eyes hurt) and URINE OUTPUT INCREASED (urinating a lot). At the time of the report, MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), OROPHARYNGEAL PAIN (throat is hurting bad), EYE PAIN (eyes hurt) and URINE OUTPUT INCREASED (urinating a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included blood pressure pills. The patients treatment information included Sumatriptan.
RASHES AND BUMPS ON FACE, NECK, ARM, BACK AND CHEST; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 14-MAR-2021, the subject experienced rashes and bumps on face, neck, arm, back and chest. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rashes and bumps on face, neck, arm, back and chest. This report was non-serious. This case is a duplicate of 20210330522.  Additional information was received from [patient] on [29/Mar/2021].  It was determined that Manufacturer Report Number [20210330522] was a duplicate of this case. All relevant information regarding this case will be submitted under Manufacturer Report Number [20210331685], upon review following corrections were amended, reported reaction term updated.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Received flu vaccine, achy, sore throat, light headed, drained of energy, x 2 days.
This spontaneous report as received from a program manager (also reported as health care worker) refers to multiple patient of unknown demographics. The patients medical history and historical conditions are not reported. It was reported that on an unknown date the patients were vaccinated with LIQUID PEDVAX (unknown strength, dose and frequency) that was stored improperly. No product quality complaint was reported. The outcome of the event is unknown. This is one of the several reports received from the same reporter (1409USA005116, 1409USA006384). Additional information has been requested.
Patient felt a tightening in the throat 10 minutes after receiving vaccine.  Vitals were stable on the way to the hospital, patient received steroids and benadryl at the hospital (no epinephrine was needed or given).  Not a true anaphylaxis, MD described as "slight allergic reaction" and is okay to get 2nd dose in 3 weeks.
Redness, swelling and increased warmth up to 5 cm x 3 cm started BACTRIM for possible local rxn and cellulitis.
(Left arm). She returned 24 hours after vaccination with a large red swollen arm at and around the site of the ZOSTAVAX injection. It was about 5 inches in diameter and very raised. She complained of pain and itching at the site.
I feel like I am dying; Muscular pain; Fatigue; I am in so much pain; I feel like I am dying, in a lot of pain; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: FF2590), via an unspecified route of administration, administered in Arm Left on 06Nov2021 (at the age of 46-year-old) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not receive prior vaccinations within 4 weeks. On Monday, 08Nov2021 the patient experienced i feel like i am dying, muscular pain, fatigue, i am in so much pain; i feel like i am dying, in a lot of pain. It was reported that, patient had muscular pain and fatigue. She was in so much pain. felt like she was dying, in a lot of pain and she could not wait. She was just going to the doctor or a hospital. She went to the doctor Thursday. He said did not take medicine. Drink teas and soup and a lot of liquid. The patient did not receive any treatment. Report was not related to a study or programme. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
I had a fever that went up to 101.6 and it stayed there from 3pm on Sat for about 36 hours (sun the 5th around 3 or 4pm). I was really out of it. I had chills and a headache. That was pretty much it.
fever, fatigue, nausea, lymph node swollen under rt arm, body aches
Spouse called a few hours post-immunization, saying her tongue was swelling - advised to take immediate treatment - pt taken the hospital and treated and kept overnight.
Severe headache for a week, theN pain in neck and then left foot was weak and I couldn?t put pressure on it
Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 3:53 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 3:53 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 19.04 years.   No concomitant medications information was reported.  On 03-Apr-2021, at 09:00 AM, vial underwent excursion with temperature of 34. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Condition of vaccine prior to administration was not frozen.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. The concurrent condition, medical history and concomitant medication was not reported. On 24-MAY-2016, the patient was vaccinated with a dose of improperly stored (Merck) PROQUAD (lot # L030587, Expiry: 10-FEB-2017). The vaccine was stored at 42.8 F for 9 hours. There were no previous temperature excursions. There were no adverse effects. This is one of the three reports received from the same reporter. Additional information has been requested.
Patient presented with an erythematous macular rash covering his abdomen. His mother immediately brought him into the hospital after noting a temperature of 101.8.   patient receive a 20mL/kg bolus of NS. He also received 50 mg/kg cefepime and 1 g ceftriaxone . For his fever, he received 10mg/kg ibuprofen and 325 mg acetaminophen.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ALLERGIC REACTION, INIT  11/05/2022 - repeat of same SYMPTOMS
A non-serious spontaneous report of sore throat and stuffy nose has been received from a 43-year-old female consumer concerning herself, subsequent to FLUMIST. Neither relevant past medical history nor concomitant medications had been reported for this patient. The patient received FLUMIST on 01-Oct-2011. On 01-Oct-2011, after receiving FLUMIST, the patient had sore throat and stuffy nose. The patient did not receive medical attention for the events. The outcome of the events sore throat and runny nose was not provided.
Information has been received from a medical assistant concerning a 78-year-old female with hypertension who on 04/10/2003 at 1:30pm was vaccinated in the left deltoid with a first 0.5mL dose of pneumococcal vaccine 23 polyvalent (Lot # 644219/1079M - multidose vial).  There was no illness at the time of vaccination.  There was no concomitant medication.  On 04/02/2003 at 08:00AM the patient developed a severe local reaction to the injection of the vaccine.  It was noted that the patient developed swelling, redness, and induration from the injection site to the elbow.  Unspecified medical attention was sought.  The reporter indicated that the patient recovered.  There were no adverse events following prior vaccinations of the patient or her siblings.  There was no product quality complaint.  The reporter also indicated that two other patients were vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot # 644219/1079M) and developed swelling, redness, and induration from the injection site down to the elbow (WAES # 0305USA01833 & WAES # 0305USA02391).  No further information is expected.
By early October I started having pain and stiffness in my right arm- unable to move it and very painful with activity.  Diagnosed first with frozen shoulder and treated for it but then as the weeks progressed the same thing happened in my left arm and then my back and hips/legs. Eventually by November I was starting to be in pain 24/7 and stiff and unable to do daily routine activities - dress myself, take a shower, get out of bed or out of a chair to standing position.
Localized redness and hives later developed itchy limbs and mouth took Benadryl.
Pain in upper right arm and neck. Started out with mild pain and progressed into severe pain in arm and neck. I finally went to a doctor and in treatment now. MRI has been done, awaiting results.
Pt recv vax on 10/27/98; 5 - 10 min later pt became diaphoretic, lightheaded, unresponsive, pulse not palpable;bradycardia, vomited; tx=ammonia capsule
This spontaneous report was received from a nurse refers to an unspecified patients of unknown age and gender. On 13-JAN-2015, the patients were vaccinated with M-M-R II INJ (strength, dose and route were not reported) (lot # K001231 and expiration date 27-JAN-2016) which were exposed to an unsupported temperature excursion. No adverse effect was reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Received call from mother. She states patient c/o nausea after injection and itchy watery eyes that evening - mother treated pt. with BENADRYL. The days later (L) upper arm red & swollen ("size of a tennis ball") with red, raised rash at edges. Six days after injection "identical" red, raised, swollen area present on (R) inner thigh.
Started having a small red area on on the neck a week after the vaccine and since then the rash has expanded to entire neck. chest, armpits. thighs. Throat feels ticklish.  has body aches.
Pt's mother brought in the patient, c/o redness and swelling to left thigh, warm to touch. Afebrile. Was seen by provider, prescribed cephalexin for 7 days and BENADRYL PRN.
Covid-19; A spontaneous report was received from a consumer concerning a 45- year old-male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced covid-19.  The patient's medical history was not provided.No relevant concomitant medications were reported.   On 26-Dec-2020,prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch 011J20A) intramuscularly on right arm for prophylaxis of COVID-19 infection.  On 21-Jan-2021,the patient tested positive (on pcr but negative on rapid test),he is asymptomatic. Laboratory data included,covid-19 PCR test positive and covid-19 rapid test negative,was provided.Treatment information was not provided.  Action taken with mRNA-1273 in response to the events  was unknown. The outcome of the event covid-19 was considered as unknown at the time of the report.
Within a few hours of getting the vaccine, I started to feel cramps and partial numbness from the last 2 fingers of my left hand. I looked up the side effects from the website and it's not listed. Four days after receiving the vaccine, I went to a care station and I was told to monitor it or see my PCP.
Shortly after receiving the second Covid shot I was in extreme pain in my vagina, volva, clitoris. It took months of testing to realize I had cytolytic vaginosis which is an overgrowth of lactobacillus. Symptoms started within the week after getting my Second Covid shot. I have been treated with multiple antibiotics to no avail.I have had multiple doctors run multiple tests all were negative except for an extreme overgrowth of lactobacillus. These tests were done in February, March, May, June. All showing negative for everything except for large amounts of lactobacillus. And extreme overgrowth of lactobacillus causes the vaginal pH to become extremely acidic which then caused the interior walls of my vagina to deteriorate. This is a rare but becoming very common vaginitis.
The night of the vaccination I could not have sex. No erection whatsoever. It feels like if I am impotent now. No morning erection either. I was fully able to have sex without any problem before the vaccination.  I also had the flu shot in the left arm. But I have had the flu shot many times before w/o issues. Hence my concern about the Covid-19 vaccine.
Pt received Tdap 8/14/17 (Monday). Monday night noticed redness without pain under bandaid. Tuesday/Wednesday increased redness and pain. Taking MOTRIN/using ice. Site is unchanged 8/17/17.
Breakthrough case admission after 4 vaccines Moderna 2/12/21 Lot# 038K20A;  Moderna 03/12/21 Lot# 007M20A;  Moderna 11/14/21 Lot# 033F21A;  Moderna 10/29/22 Lot# 050D22A
Swelling, soreness of the injection site...the injection area a week later is still hot to the touch and has increased in area size.  It itches and has been dispersing in that area into patch like hive. The itches has moved to thigh area on left and right sides of body. I have also had a dull burning like sensation in the front area of my forehead.  I have also been rubbing the left side of my face when the tingling numbness appears.left work Wednesday due to being so nauseated.
Blood pressure 136; Front and nose filled with mucus; As if her ears were filled with air; Sore arm; Headache; Tiredness; This spontaneous case was reported by a non-health professional and describes the occurrence of HYPERTENSION (Blood pressure 136), NASAL CONGESTION (Front and nose filled with mucus), EAR DISCOMFORT (As if her ears were filled with air), VACCINATION SITE PAIN (Sore arm) and HEADACHE (Headache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Irregular menstrual cycle (she got her menstrual period after one year). Concomitant products included LOPERAMIDE HYDROCHLORIDE (IMODIUM) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HYPERTENSION (Blood pressure 136), NASAL CONGESTION (Front and nose filled with mucus), EAR DISCOMFORT (As if her ears were filled with air), VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness). At the time of the report, HYPERTENSION (Blood pressure 136), NASAL CONGESTION (Front and nose filled with mucus), EAR DISCOMFORT (As if her ears were filled with air), HEADACHE (Headache) and FATIGUE (Tiredness) outcome was unknown and VACCINATION SITE PAIN (Sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Blood pressure measurement: 136.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Starting at noon on February 27th I became very nauseous and it continued through now. Starting at 9am February 28th I began to have frequent bouts of diarrhea that have continued through now, including 12 trips to the bathroom with diarrhea between 9am and now (10:30pm).